Research Grade Cefixime Compound Overview
Zimaks 400 Bilim is a research-grade laboratory compound containing cefixime, a third-generation cephalosporin antibiotic developed for in-vitro microbiological and cellular research applications. This pharmaceutical reference standard enables researchers to study beta-lactam antimicrobial mechanisms, bacterial resistance patterns, and cephalosporin pharmacology in controlled laboratory environments. Scientists investigating antimicrobial research can examine this compound’s effects on cell wall synthesis pathways and beta-lactamase interactions. The formulation provides consistent analytical results for laboratories studying gram-positive and gram-negative bacterial response mechanisms.
Research teams at Stroid UK Shop utilise this compound alongside other pharmaceutical references from our cefixime research collection to investigate antibiotic resistance mechanisms and microbial sensitivity patterns. The compound demonstrates particular value in studies examining porins, penicillin-binding proteins, and efflux pump mechanisms in bacterial cell culture models.
Laboratory Research Applications
Cefixime research enables comprehensive investigation of third-generation cephalosporin mechanisms in laboratory settings. Researchers examine this compound’s effects on bacterial cell wall peptidoglycan synthesis, studying how beta-lactam ring structures interact with penicillin-binding proteins in various gram-positive and gram-negative bacterial species. Microbiological studies investigate minimal inhibitory concentration protocols, time-kill kinetics, and synergistic interactions with other antimicrobial agents.
The compound proves valuable for laboratories studying beta-lactamase resistance mechanisms, particularly extended-spectrum beta-lactamases (ESBLs) and AmpC-type enzymes. Research teams analyse how structural modifications affect antimicrobial stability and examine resistance gene expression patterns in bacterial cultures. Additional applications include investigating oral bioavailability models, protein binding studies, and tissue distribution analysis in appropriate research systems.
Technical Specifications
| Parameter | Specification |
|---|---|
| Product Code | EU1752 |
| Active Component | Cefixime |
| Formulation | Bilim pharmaceutical standard |
| Concentration | 400mg research grade |
| Molecular Formula | C₁₆H₁₅N₅O₇S₂ |
| CAS Number | 79350-37-1 |
| Molecular Weight | 453.45 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Laboratory reference standard |
Laboratories studying similar antimicrobial mechanisms may investigate complementary compounds from our SARMs research collection for receptor binding studies or explore our peptides research range for antimicrobial peptide comparisons.
Research Compliance Statement
Zimaks 400 Bilim is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. This product must not be used for human consumption, therapeutic treatment, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols, proper chemical handling procedures, and compliance with institutional research guidelines when studying this compound. All experimental work should occur within controlled laboratory environments under qualified scientific supervision, following established microbiological research protocols and antimicrobial testing standards.
